ADME-Tox screening is system is an integrated workstation for describing of the absorption, distribution, metabolism, and excretion properties of drug molecules. ADME-Tox screening system includes biochemical assay tester which measures the physicochemical properties of a drug molecule. This system also supports the permeability assays testing which measures the drug affinity toward metabolic enzyme. ADME-Tox screening system is enabled with highly integrated software which has an inbuilt protocol for the sample testing. The protocol feed in the software can be edited as per the customized need of sample testing. ADME-Tox screening system is connected to the multi-mode reader which allows runs the wide range of protocol on primary and secondary screen. This system provide accurate toxicity test for the drug development and biopharmaceutical production.
Scope of the Report:
This report focuses on the ADME-Tox Screening Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The increasing focus of drug manufacturer to reduce the development cost of drug with least toxicological issue is the major factor driving the growth of ADME-Tox screening system market. Beside the ADME-Toxicological testing increases the potential of drug which increases the efficiency of the drug to target the desired tissue. Moreover, increasing demand for specialized drug due to rising prevalence of various chronic diseases will also upsurge the growth of AME-Tox screening system market. High installation and maintenance cost of this system will hamper the growth of this market. Additionally, lack of skilled professional to operate this system will also responsible for the sluggish growth of this market.
North America is expected to dominate the ADME-Tox screening system market due to the presence of a large number of biopharmaceutical companies in this region. Europe and Asia-Pacific will follow the North America for the ADME-Tox screening system market. In Asia-Pacific India and China are expected to be fastest growing market over the forecast period owing increased focus of leading biopharmaceutical manufacturer to expand their subsidiaries in these countries.
The worldwide market for ADME-Tox Screening Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Hudson Robotics
Agilent Tsechnologies
ADMEcell
BioreclamationIVT
Beckman Counter
Cerep
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instruments
Assay system
Software
Market Segment by Applications, can be divided into
Discovery and Development
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Others
There are 15 Chapters to deeply display the global ADME-Tox Screening Systems market.
Chapter 1, to describe ADME-Tox Screening Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of ADME-Tox Screening Systems, with sales, revenue, and price of ADME-Tox Screening Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of ADME-Tox Screening Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, ADME-Tox Screening Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe ADME-Tox Screening Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 ADME-Tox Screening Systems Introduction
1.2 Market Analysis by Type
1.2.1 Instruments
1.2.2 Assay system
1.2.3 Software
1.3 Market Analysis by Applications
1.3.1 Discovery and Development
1.3.2 Biopharmaceutical Production
1.3.3 Drug Screening
1.3.4 Tissue Engineering
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hudson Robotics
2.1.1 Business Overview
2.1.2 ADME-Tox Screening Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hudson Robotics ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Agilent Tsechnologies
2.2.1 Business Overview
2.2.2 ADME-Tox Screening Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Agilent Tsechnologies ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 ADMEcell
2.3.1 Business Overview
2.3.2 ADME-Tox Screening Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ADMEcell ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BioreclamationIVT
2.4.1 Business Overview
2.4.2 ADME-Tox Screening Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioreclamationIVT ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Beckman Counter
2.5.1 Business Overview
2.5.2 ADME-Tox Screening Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Beckman Counter ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cerep
2.6.1 Business Overview
2.6.2 ADME-Tox Screening Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cerep ADME-Tox Screening Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global ADME-Tox Screening Systems Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global ADME-Tox Screening Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global ADME-Tox Screening Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 ADME-Tox Screening Systems Manufacturer Market Share in 2017
3.3.2 Top 6 ADME-Tox Screening Systems Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global ADME-Tox Screening Systems Market Analysis by Regions
4.1 Global ADME-Tox Screening Systems Sales, Revenue and Market Share by Regions
4.1.1 Global ADME-Tox Screening Systems Sales and Market Share by Regions (2013-2018)
4.1.2 Global ADME-Tox Screening Systems Revenue and Market Share by Regions (2013-2018)
4.2 North America ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
4.3 Europe ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
4.5 South America ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
5 North America ADME-Tox Screening Systems by Countries
5.1 North America ADME-Tox Screening Systems Sales, Revenue and Market Share by Countries
5.1.1 North America ADME-Tox Screening Systems Sales and Market Share by Countries (2013-2018)
5.1.2 North America ADME-Tox Screening Systems Revenue and Market Share by Countries (2013-2018)
5.2 United States ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
5.3 Canada ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
5.4 Mexico ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
6 Europe ADME-Tox Screening Systems by Countries
6.1 Europe ADME-Tox Screening Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe ADME-Tox Screening Systems Sales and Market Share by Countries (2013-2018)
6.1.2 Europe ADME-Tox Screening Systems Revenue and Market Share by Countries (2013-2018)
6.2 Germany ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
6.3 UK ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
6.4 France ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
6.5 Russia ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
6.6 Italy ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
7 Asia-Pacific ADME-Tox Screening Systems by Countries
7.1 Asia-Pacific ADME-Tox Screening Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific ADME-Tox Screening Systems Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific ADME-Tox Screening Systems Revenue and Market Share by Countries (2013-2018)
7.2 China ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
7.3 Japan ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
7.4 Korea ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
7.5 India ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
7.6 Southeast Asia ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
8 South America ADME-Tox Screening Systems by Countries
8.1 South America ADME-Tox Screening Systems Sales, Revenue and Market Share by Countries
8.1.1 South America ADME-Tox Screening Systems Sales and Market Share by Countries (2013-2018)
8.1.2 South America ADME-Tox Screening Systems Revenue and Market Share by Countries (2013-2018)
8.2 Brazil ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
8.3 Argentina ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
8.4 Colombia ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
9 Middle East and Africa ADME-Tox Screening Systems by Countries
9.1 Middle East and Africa ADME-Tox Screening Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa ADME-Tox Screening Systems Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa ADME-Tox Screening Systems Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
9.3 UAE ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
9.4 Egypt ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
9.5 Nigeria ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
9.6 South Africa ADME-Tox Screening Systems Sales and Growth Rate (2013-2018)
10 Global ADME-Tox Screening Systems Market Segment by Type
10.1 Global ADME-Tox Screening Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global ADME-Tox Screening Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global ADME-Tox Screening Systems Revenue and Market Share by Type (2013-2018)
10.2 Instruments Sales Growth and Price
10.2.1 Global Instruments Sales Growth (2013-2018)
10.2.2 Global Instruments Price (2013-2018)
10.3 Assay system Sales Growth and Price
10.3.1 Global Assay system Sales Growth (2013-2018)
10.3.2 Global Assay system Price (2013-2018)
10.4 Software Sales Growth and Price
10.4.1 Global Software Sales Growth (2013-2018)
10.4.2 Global Software Price (2013-2018)
11 Global ADME-Tox Screening Systems Market Segment by Application
11.1 Global ADME-Tox Screening Systems Sales Market Share by Application (2013-2018)
11.2 Discovery and Development Sales Growth (2013-2018)
11.3 Biopharmaceutical Production Sales Growth (2013-2018)
11.4 Drug Screening Sales Growth (2013-2018)
11.5 Tissue Engineering Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 ADME-Tox Screening Systems Market Forecast (2018-2023)
12.1 Global ADME-Tox Screening Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 ADME-Tox Screening Systems Market Forecast by Regions (2018-2023)
12.2.1 North America ADME-Tox Screening Systems Market Forecast (2018-2023)
12.2.2 Europe ADME-Tox Screening Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific ADME-Tox Screening Systems Market Forecast (2018-2023)
12.2.4 South America ADME-Tox Screening Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa ADME-Tox Screening Systems Market Forecast (2018-2023)
12.3 ADME-Tox Screening Systems Market Forecast by Type (2018-2023)
12.3.1 Global ADME-Tox Screening Systems Sales Forecast by Type (2018-2023)
12.3.2 Global ADME-Tox Screening Systems Market Share Forecast by Type (2018-2023)
12.4 ADME-Tox Screening Systems Market Forecast by Application (2018-2023)
12.4.1 Global ADME-Tox Screening Systems Sales Forecast by Application (2018-2023)
12.4.2 Global ADME-Tox Screening Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure ADME-Tox Screening Systems Picture
Table Product Specifications of ADME-Tox Screening Systems
Figure Global Sales Market Share of ADME-Tox Screening Systems by Types